‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
Keeping Current
Adjuvant EGFR TKI Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Current and Future Perspectives
30
00:00:00
/ 00:50:38
30